SCHEMBL23517890

SCHEMBL23517890

c1ccc(-c2cccc(-c3nc(-c4ccccc4)nc(-c4cc(-c5ccc6c7ccccc7c7ccccc7c6c5)c5c(c4)oc4ccccc45)n3)c2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 4/20 0.38
PLA2G4A P47712 4/20 0.38
PLA2G10 O15496 1/20 0.38
HCRTR1 O43613 1/20 0.34
MMP12 P39900 1/20 0.33
MMP13 P45452 1/20 0.33
HSD17B1 P14061 1/20 0.33
HSD17B2 P37059 1/20 0.33
MAPT P10636 3/20 0.33
KMT2A Q03164 2/20 0.33
LMNA P02545 1/20 0.33
POLB P06746 1/20 0.33
TSHR P16473 1/20 0.33
HTT P42858 1/20 0.33
TERT O14746 1/20 0.32
PRKDC P78527 1/20 0.32
ALOX5 P09917 1/20 0.32
GAA P10253 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
ALDH1A1 P00352 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23517507 0.99 PLA2G2A (0.39) PLA2G2APLA2G4APLA2G10HCRTR1HSD17B1
SCHEMBL23312520 0.99 PLA2G2A (0.39) PLA2G2APLA2G4APLA2G10HCRTR1HSD17B1
SCHEMBL23312773 0.99 PLA2G2A (0.39) PLA2G2APLA2G4APLA2G10HCRTR1MMP12
SCHEMBL23312403 0.96 PLA2G2A (0.39) PLA2G2APLA2G4APLA2G10HCRTR1HSD17B1
SCHEMBL23312698 0.96 PLA2G2A (0.36) PLA2G2APLA2G4APLA2G10HCRTR1MMP12
SCHEMBL23517489 0.96 PLA2G2A (0.36) PLA2G2APLA2G4APLA2G10HCRTR1MMP12
SCHEMBL23517764 0.95 PLA2G2A (0.39) PLA2G2APLA2G4APLA2G10HCRTR1MMP12
SCHEMBL23312644 0.95 PLA2G2A (0.39) PLA2G2APLA2G4APLA2G10HCRTR1MMP12
SCHEMBL23312720 0.95 PLA2G2A (0.39) PLA2G2APLA2G4APLA2G10HCRTR1MMP12
SCHEMBL23312777 0.95 MAPT (0.35) PLA2G2APLA2G4APLA2G10HCRTR1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12018022-B2 Heterocyclic compound, organic light emitting diode comprising same, composition for organic layer of organic light emitting diode, and method for manufacturing organic light emitting diode LT MATERIALS CO., LTD. (KR) 2024-06-25 US disclosed
US-12018022-B2 Heterocyclic compound, organic light emitting diode comprising same, composition for organic layer of organic light emitting diode, and method for manufacturing organic light emitting diode LT MATERIALS CO., LTD. (KR) 2024-06-25 US disclosed
US-20210179596-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DIODE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT EMITTING DIODE, AND METHOD FOR MANUFACTURING ORGANIC LIGHT EMITTING DIODE LT MATERIALS CO., LTD. (KR) 2021-06-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12018022-B2 Heterocyclic compound, organic light emitting diode comprising same, composition for organic layer of organic light emitting diode, and method for manufacturing organic light emitting diode ODC1, AOX1, CYP1B1 PLA2G2A 4706/4885PLA2G4A 4584/4885PLA2G10 4684/4885
US-20210179596-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DIODE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT EMITTING DIODE, AND METHOD FOR MANUFACTURING ORGANIC LIGHT EMITTING DIODE ODC1, AOX1, CYP1B1 PLA2G2A 4706/4885PLA2G4A 4584/4885PLA2G10 4684/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.